Literature DB >> 26600799

Expanding Endovascular Therapy of Very Small Ruptured Aneurysms with the 1.5-mm Coil.

Thanh N Nguyen1, Hesham Masoud2, Nicholas Tarlov3, James Holsapple4, Lawrence S Chin5, Alexander M Norbash6.   

Abstract

BACKGROUND: Very small ruptured aneurysms (≤3 mm) demonstrate a significant risk for procedural rupture with endovascular therapy. Since 2007, 1.5-mm-diameter coils have been available (Micrus, Microvention, and ev3), allowing neurointerventionalists the opportunity to offer patients with very small aneurysms endovascular treatment. In this study, we review the clinical and angiographic outcome of patients with very small ruptured aneurysms treated with the 1.5-mm coil.
METHODS: This is a retrospective cohort study in which we examined consecutive ruptured very small aneurysms treated with coil embolization at a single institution. The longest linear aneurysm was recorded, even if the first coil was sized to a smaller transverse diameter. Very small aneurysms were defined as ≤3 mm. Descriptive results are presented.
RESULTS: From July 2007 to March 2015, 81 aneurysms were treated acutely with coils in 78 patients presenting with subarachnoid hemorrhage. There were 5 patients with 3-mm aneurysms, of which the transverse diameter was ≤2 mm in 3 patients. In all 5 patients, a balloon was placed for hemostatic prophylaxis in case of rupture, and a single 1.5-mm coil was inserted for aneurysm treatment without complication. Complete aneurysm occlusion was achieved in 1 patient, residual neck in 2, and residual aneurysm in 2 patients. Aneurysm recanalization was present in 2 patients with an anterior communicating artery aneurysm; a recoiling attempt was unsuccessful in 1 of these 2 patients due to inadvertent displacement and distal coil embolization, but subsequent surgical clipping was successful. Another patient was retreated by surgical clipping for a residual wide-neck carotid terminus aneurysm. One patient died of ventriculitis 3 weeks after presentation; all 4 other patients had an excellent outcome with no rebleed at follow-up (mean 21 months, range 1-62).
CONCLUSION: The advent of the 1.5-mm coil may be used in the endovascular treatment of patients with very small ruptured aneurysms, providing a temporary protection to the site of rupture in the acute phase. If necessary, bridging with elective clipping may provide definitive aneurysm treatment.

Entities:  

Keywords:  Coil embolization; Endovascular therapy; Very small ruptured aneurysms

Year:  2015        PMID: 26600799      PMCID: PMC4640086          DOI: 10.1159/000437275

Source DB:  PubMed          Journal:  Interv Neurol        ISSN: 1664-5545


  11 in total

1.  Small aneurysm size is a risk factor for perforation during coiling.

Authors:  Menno Sluzewski; Willem Jan Van Rooij
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

2.  Ultra-small diameter coils for treatment of intracranial aneurysms.

Authors:  Gaurav Jindal; Timothy Miller; Narlin Beaty; Ajit Puri; Dheeraj Gandhi
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

3.  Endovascular coil embolization of very small intracranial aneurysms.

Authors:  Jin Ho Hwang; Hong Gee Roh; Young Il Chun; Hyun-Seung Kang; Jin Woo Choi; Won-Jin Moon; Joon Cho; Chang Taek Moon; Young Cho Koh
Journal:  Neuroradiology       Date:  2010-06-24       Impact factor: 2.804

4.  Endovascular therapy of very small aneurysms of the anterior communicating artery: five-fold increased incidence of rupture.

Authors:  Albert J Schuette; Ferdinand K Hui; Alejandro M Spiotta; Nancy A Obuchowski; Rishi Gupta; Shaye I Moskowitz; Frank C Tong; Jacques E Dion; Charles M Cawley
Journal:  Neurosurgery       Date:  2011-03       Impact factor: 4.654

5.  Balloon-assisted extrasaccular coil embolization technique for the treatment of very small cerebral aneurysms.

Authors:  Alberto Gil; Pedro Vega; Eduardo Murias; Hugo Cuellar
Journal:  J Neurosurg       Date:  2010-03       Impact factor: 5.115

6.  Clinical and angiographic results of coiling of 196 very small (< or = 3 mm) intracranial aneurysms.

Authors:  W J van Rooij; G J Keeren; J P P Peluso; M Sluzewski
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-08       Impact factor: 3.825

7.  Association of endovascular therapy of very small ruptured aneurysms with higher rates of procedure-related rupture.

Authors:  Thanh N Nguyen; Jean Raymond; François Guilbert; Daniel Roy; Maxime D Bérubé; Mostafa Mahmoud; Alain Weill
Journal:  J Neurosurg       Date:  2008-06       Impact factor: 5.115

8.  Coil embolization of very small (2 mm or smaller) berry aneurysms: feasibility and technical issues.

Authors:  V Gupta; M Chugh; A N Jha; B S Walia; S Vaishya
Journal:  AJNR Am J Neuroradiol       Date:  2008-11-11       Impact factor: 3.825

9.  Endovascular coil embolization of very small intracranial aneurysms.

Authors:  Kil Sung Chae; Pyoung Jeon; Keon Ha Kim; Sung Tae Kim; Hyung Jin Kim; Hong Sik Byun
Journal:  Korean J Radiol       Date:  2010-08-27       Impact factor: 3.500

10.  Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up.

Authors:  Andrew J Molyneux; Richard S C Kerr; Jacqueline Birks; Najib Ramzi; Julia Yarnold; Mary Sneade; Joan Rischmiller
Journal:  Lancet Neurol       Date:  2009-03-28       Impact factor: 44.182

View more
  2 in total

1.  Safety and efficacy of endovascular treatment of ruptured tiny cerebral aneurysms compared with ruptured larger aneurysms.

Authors:  Ji-Wei Wang; Cong-Hui Li; Yang-Yang Tian; Xin-Yu Li; Jian-Feng Liu; Hui Li; Bu-Lang Gao
Journal:  Interv Neuroradiol       Date:  2020-01-13       Impact factor: 1.610

2.  Early major recurrence of cerebral aneurysms after satisfactory initial coiling.

Authors:  Mohamad Abdalkader; Jean Raymond; Asim Mian; Varun Naragum; Katharine Cronk; Daniel Roy; Alain Weill; Thanh N Nguyen
Journal:  Interv Neuroradiol       Date:  2020-10-20       Impact factor: 1.610

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.